Results of combined phacoemulsification and viscocanalostomy in patients with cataract and pseudoexfoliative glaucoma

Coexisting pseudoexfoliation glaucoma (PEXG) and cataract represents a special challenge. Although phacotrabeculectomy is an effective procedure, it combines the risks of phacoemulsification and trabeculectomy. This study evaluates phacoviscocanalostomy to manage eyes with PEXG and cataract. We cond...

Full description

Saved in:
Bibliographic Details
Published in:European journal of ophthalmology 2008-03, Vol.18 (2), p.212-219
Main Authors: Hassan, K M, Awadalla, M A
Format: Article
Language:English
Subjects:
Aged
Antihypertensive Agents - therapeutic use
Cataract - complications
Cataract - therapy
Exfoliation Syndrome - complications
Exfoliation Syndrome - surgery
Female
Filtering Surgery - methods
Glaucoma - complications
Glaucoma - surgery
Humans
Intraocular Pressure
Intraoperative Complications
Lens Implantation, Intraocular
Male
Phacoemulsification - methods
Postoperative Complications
Prospective Studies
Sclera - surgery
Surgical Flaps
Treatment Outcome
Visual Acuity
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Coexisting pseudoexfoliation glaucoma (PEXG) and cataract represents a special challenge. Although phacotrabeculectomy is an effective procedure, it combines the risks of phacoemulsification and trabeculectomy. This study evaluates phacoviscocanalostomy to manage eyes with PEXG and cataract. We conducted a prospective noncomparative study that included 30 consecutive eyes of 22 patients with uncontrolled PEXG and cataract. Phacoviscocanalostomy was performed in all. Success rate based on postoperative intraocular pressure (IOP) reduction and requirement for topical antiglaucoma medication was evaluated as the main outcome measure. Visual acuity and complication rates were secondary outcomes. The mean follow-up was 18.6 months +/-6.2 (SD) (range 12 to 36 months). There was statistically significant decrease in mean IOP from 25.3+/-5.2 mmHg preoperatively to 13.5+/-6.0 mmHg 1 day after surgery (p< .05), 12.3+/-3.1 mmHg at the final follow-up (p< .05), and at all evaluations to the last postoperative visit. Only three eyes (10%) required a single antiglaucoma medication to achieve the target IOP. A complete surgical success (IOP
ISSN:1120-6721
1724-6016
DOI:10.1177/112067210801800208